Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medeze Group PCLBKK:MEDEZE -1.59%19 Operating Margin % is 21.65% as of Jun. 2026, which is 50% below its 10-year median of 43.37. GuruFocus rates BKK:MEDEZE with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Medeze Group PCL ranks better than 95.68% on this metric.
The historical rank and industry rank for Medeze Group PCL's Operating Margin % or its related term are showing as below:
BKK:MEDEZE'
s Operating Margin % Range Over the Past 10 Years
Min: 26.82 Med: 43.37 Max: 43.87
Current: 26.82
BKK:MEDEZE's Operating Margin % is ranked better than 95.68% of 672
companies
in the Healthcare Providers & Services industry
Industry Median: 5.03
vs BKK:MEDEZE: 26.82
Medeze Group PCL's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Medeze Group PCL (BKK:MEDEZE) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Medeze Group PCL Operating Margin % Related Terms
Medeze Group PCL Operating Margin % Historical Data
* Premium members only.
The historical data trend for Medeze Group PCL's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:MEDEZE vs HCA, THC, EHC: Operating Margin % Comparison
For the Medical Care Facilities subindustry, Medeze Group PCL's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medeze Group PCL Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Medeze Group PCL's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Medeze Group PCL's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medeze Group PCL (BKK:MEDEZE) has a Operating Margin % of 21.65% as of Jun. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Medeze Group PCL and its competitors. This is 50% below median its historical median of 43.37. Over the past decade, Medeze Group PCL's Operating Margin % has ranged from 26.82 to 43.87. According to the industry distribution chart, Medeze Group PCL ranks #29 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 4.3%.
Is Medeze Group PCL's Operating Margin % too high?
Medeze Group PCL's current Operating Margin % of 21.65% is 50% below median its 10-year median of 43.37. Over the past 10 years, this metric has ranged from a low of 26.82 to a high of 43.87. The Healthcare Providers & Services industry median Operating Margin % is 5.03. Medeze Group PCL's value of 21.65% is 330.4% above this industry median. Based on the distribution chart, Medeze Group PCL ranks #29 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medeze Group PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medeze Group PCL's Operating Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medeze Group PCL ranks #29 out of 672 companies for Operating Margin %. This places Medeze Group PCL in the top 4% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 5.03. Medeze Group PCL's value of 21.65% is 330.4% above this benchmark. Historically, Medeze Group PCL's own Operating Margin % has ranged from 26.82 to 43.87 over the past decade. While the company's 10-year median is 43.37 vs. the industry median of 5.03, Medeze Group PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 5.03, based on 672 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medeze Group PCL's current Operating Margin % of 21.65% is 330.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Medeze Group PCL and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 5.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medeze Group PCL's current Operating Margin % is 21.65%, which is 50% below median its own 10-year median of 43.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeze Group PCL stock overvalued right now?
Medeze Group PCL (BKK:MEDEZE) has a current Operating Margin % of 21.65%. The current Operating Margin % is 21.65%, which is 50% below median its 10-year median of 43.37 and 330.4% above the Healthcare Providers & Services industry median of 5.03. Medeze Group PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Medeze Group PCL (BKK:MEDEZE), the current Operating Margin % is 21.65% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
19GF Score
Get the complete analysis for BKK:MEDEZE
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MEDEZE has been successfully added to your 
